ARCHIVES

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 7 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects

April 30, 2010

Supreme Court Lets Stand Lower Court Ruling On AZT Patents

January 19, 1996

Proposed DRG Regulations Would Limit Exemptions To Fox Chase, M.D. Anderson; In Effect Oct. 1

September 9, 1983

CVS To Stop Tobacco Sales at Pharmacies

February 7, 2014

Study Finds That CTC Was Used Correctly In Medicare Patients

April 26, 2013

Treatment research Reports Summarized; New MTX Rescues

May 6, 1977